APTENSIO XR FDA approval date

The FDA approved APTENSIO XR on 17 Apr 2015.

FDA approval date
17 Apr 2015

Drug identity has not yet been verified against registry records

Also recorded as METHYLPHENIDATE HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2015-04-17DayAPTENSIO XRFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205831", "applicant_as_listed_by_fda": "RHODES PHARMS", "brand_names": ["APTENSIO XR"], "active_ingredients": ["METHYLPHENIDATE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150417", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026